FDA Inspection 1075268 — Ari-Med Pharmaceuticals

Ari-Med Pharmaceuticals — FEI 2027206

The FDA completed an inspection of Ari-Med Pharmaceuticals on November 15, 2018 in Tempe, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 15, 2018
Fiscal Year
2019
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Tempe, AZ (United States)